Загрузка...
Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial
Sexual dysfunction commonly occurs with major depressive disorder (MDD). Vilazodone, a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist antidepressant approved for the treatment of MDD in adults, was evaluated to determine its effects on sexual function. The primary study...
Сохранить в:
| Опубликовано в: : | Int Clin Psychopharmacol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams And Wilkins
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457500/ https://ncbi.nlm.nih.gov/pubmed/26039688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000075 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|